NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive announced a quarterly dividend on Thursday, January 10th. Stockholders of record on Wednesday, January 23rd will be paid a dividend of $0.42 per share on Friday, February 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.68%. The ex-dividend date of this dividend is Tuesday, January 22nd. View Colgate-Palmolive's Dividend History.

Colgate-Palmolive announced that its Board of Directors has authorized a stock repurchase program on Monday, June 18th 2018, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive (NYSE:CL) posted its earnings results on Friday, October, 26th. The company reported $0.72 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.72. The firm earned $3.85 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The company's revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.73 EPS. View Colgate-Palmolive's Earnings History.

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, January 25th 2019. View Earnings Estimates for Colgate-Palmolive.

Colgate-Palmolive will be holding an earnings conference call on Friday, January 25th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

16 brokerages have issued 12 month price targets for Colgate-Palmolive's shares. Their predictions range from $54.00 to $79.00. On average, they anticipate Colgate-Palmolive's share price to reach $66.7857 in the next year. This suggests a possible upside of 6.6% from the stock's current price. View Analyst Price Targets for Colgate-Palmolive.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

Headlines about CL stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Colgate-Palmolive earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the company's share price in the next several days.

Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Coty (COTY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Revlon (REV), Mandom (MDOMF), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), 2050 Motors (ETFM) and DS Healthcare Group (DSKX).

Colgate-Palmolive's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Genesis Asset Managers LLP (0.29%), Confluence Investment Management LLC (0.18%), Packer & Co Ltd (0.14%), LGT Capital Partners LTD. (0.11%), Gateway Investment Advisers LLC (0.09%) and BTIM Corp. (0.07%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including Genesis Asset Managers LLP, Gulf International Bank UK Ltd, Bath Savings Trust Co, Wendell David Associates Inc., Boston Advisors LLC, Davis R M Inc., Bristlecone Advisors LLC and DNB Asset Management AS. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin and Philip G Shotts. View Insider Buying and Selling for Colgate-Palmolive.

CL stock was bought by a variety of institutional investors in the last quarter, including Packer & Co Ltd, USS Investment Management Ltd, Rockland Trust Co., Bright Rock Capital Management LLC, Virtu Financial LLC, Oakbrook Investments LLC, R.H. Dinel Investment Counsel Inc. and Deane Retirement Strategies Inc.. View Insider Buying and Selling for Colgate-Palmolive.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CL stock can currently be purchased for approximately $62.63.

Colgate-Palmolive has a market capitalization of $53.77 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.

The official website for Colgate-Palmolive is http://www.colgate.com/en-us/en/us/oc.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]